Comparison of Lumbar Muscle Thickness Measurements in Osteoporotic and Osteopenic Patients - Trial NCT05823558
Access comprehensive clinical trial information for NCT05823558 through Pure Global AI's free database. This phase not specified trial is sponsored by Sisli Hamidiye Etfal Training and Research Hospital and is currently Not yet recruiting. The study focuses on Osteoporosis. Target enrollment is 300 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Sisli Hamidiye Etfal Training and Research Hospital
Timeline & Enrollment
N/A
May 01, 2023
Aug 01, 2023
Primary Outcome
Lomber Muscle Measurement
Summary
In osteoporosis, sarcopenia is a common condition. Sarcopenic measurements can be made by
 evaluating muscle thickness in different regions. We aim to evaluate lumbar muscle losses in
 patients with osteoporosis in the lumbar region and to examine whether these muscle losses
 are correlated with the level of osteoporosis. The patients will be divided into 3 groups as
 healthy, osteopenic and osteoporotic according to DEXA measurements. Demographic values,
 comorbidities, osteoporosis drugs used, fracture histories, L1-4, L2-4, femoral neck and
 total BMD and t values of the patients, psoas and multifidus muscle measurements will be made
 at L2-L3 level in Lumbar MR imaging. Lumbar MR muscle measurements will be made by 1
 physician blind to the DEXA values of the patients.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05823558
Non-Device Trial